All companies
Visit website
Neureka® for Epilepsy
OperatingNovela Neurotechnologies, Inc.
Healthcare · Founded 2018
Woman-foundedImmigrant-founded
Epilepsy care reimagines: AI-powered wearables for on-demand care, 24/7
Valuation cap ⓘ
$25.0M
As of Apr 2023 · from Neureka for Epilepsy Crowd SAFE 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$87,101
Across 1 round since 2023
Financials
FY2020–FY2023 · from SEC filings · hover any figure for its source$0
−$962K
2020
$0
−$1.4M
2021
$225K
−$986K
2022
−$140K
−$1.2M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
Income statement
Revenue
$0
$0
$225,244
-$139,685
Cost of goods sold
$0
$0
$38,511
$42,435
Gross margin
—
—
83%
—
Net income
-$962,316
-$1,393,497
-$986,188
-$1,192,435
Taxes paid
$0
$0
$1,904
$3,205
Balance sheet
Cash
$64,459
$281,299
$60,200
$99,207
Accounts receivable
$0
$0
$217,700
$0
Total assets
$71,179
$286,340
$2,628,933
$2,289,146
Short-term debt
$34,704
$50,065
$23,156
$12,579
Long-term debt
$42,167
$20,171
$2,069,466
$2,019,466
Total liabilities
$76,871
$70,236
$2,092,622
$2,032,045
Other
Headcount
—
2
—
2
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$25.0M
Valuation cap
Neureka for Epilepsy Crowd SAFE 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $87.1K / $1.2MInvestors 100Valuation cap $25M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 1 of 4 annual reports (FY2022–FY2025)
100 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001768586
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.